share_log

康方生物-B:內幕消息公告 - 與SUMMIT THERAPEUTICS INC.訂立關於依沃西(PD-1/VEGF雙特異性)高達50億美元的許可協議

AKESO, INC. - B: INSIDE INFORMATION ANNOUNCEMENT - ENTERING INTO LICENSE AGREEMENT FOR UP TO US$5 BILLION FOR IVONESCIMAB (PD-1/VEGF BISPECIFIC) WITH SUMMIT THERAPEUTICS INC.

Dec 6, 2022 07:55
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more